Menu

Filtros : "EVORA, PAULO ROBERTO BARBOSA" "Soares, Ricardo Oliveira dos Santos" Limpar

Filtros

Limitar por data

  • 1

1 - 3 (3 registros)

  • Artigo de periodico

    Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating (2022)

    Soares, Ricardo Oliveira dos Santos; Albuquerque, Agnes Afrodite Sumarelli; Evora, Paulo Roberto Barbosa

    Fonte: Current Drug Targets. Unidade: FMRP

    Assuntos: ISQUEMIA, ENDOTÉLIO VASCULAR, SISTEMA CARDIOVASCULAR

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SOARES, Ricardo Oliveira dos Santos e ALBUQUERQUE, Agnes Afrodite Sumarelli e EVORA, Paulo Roberto Barbosa. Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating. Current Drug Targets, v. 23, n. 12, p. 1128-1132, 2022Tradução . . Disponível em: https://doi.org/10.2174/1389450123666220519170221. Acesso em: 02 nov. 2024.

    • APA

      Soares, R. O. dos S., Albuquerque, A. A. S., & Evora, P. R. B. (2022). Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating. Current Drug Targets, 23( 12), 1128-1132. doi:10.2174/1389450123666220519170221

    • NLM

      Soares RO dos S, Albuquerque AAS, Evora PRB. Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating [Internet]. Current Drug Targets. 2022 ; 23( 12): 1128-1132.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/1389450123666220519170221

    • Vancouver

      Soares RO dos S, Albuquerque AAS, Evora PRB. Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating [Internet]. Current Drug Targets. 2022 ; 23( 12): 1128-1132.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/1389450123666220519170221

  • Artigo de periodico

    After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery (2021)

    Evora, Paulo Roberto Barbosa; Soares, Ricardo Oliveira dos Santos; Bassetto, Solange; Martins, Maria Auxiliadora; Silva, Fábio Luis da; Basile-Filho, Anibal

    Fonte: Brazilian Journal of Cardiovascular Surgery. Unidade: FMRP

    Assuntos: PROCEDIMENTOS CIRÚRGICOS CARDÍACOS, HIPOTENSÃO, AZUL DE METILENO, FARMACOTERAPIA

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      EVORA, Paulo Roberto Barbosa et al. After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery. Brazilian Journal of Cardiovascular Surgery, v. 36, n. 3, p. 406-411, 2021Tradução . . Disponível em: https://doi.org/10.21470/1678-9741-2021-0955. Acesso em: 02 nov. 2024.

    • APA

      Evora, P. R. B., Soares, R. O. dos S., Bassetto, S., Martins, M. A., Silva, F. L. da, & Basile-Filho, A. (2021). After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery. Brazilian Journal of Cardiovascular Surgery, 36( 3), 406-411. doi:10.21470/1678-9741-2021-0955

    • NLM

      Evora PRB, Soares RO dos S, Bassetto S, Martins MA, Silva FL da, Basile-Filho A. After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery [Internet]. Brazilian Journal of Cardiovascular Surgery. 2021 ; 36( 3): 406-411.[citado 2024 nov. 02 ] Available from: https://doi.org/10.21470/1678-9741-2021-0955

    • Vancouver

      Evora PRB, Soares RO dos S, Bassetto S, Martins MA, Silva FL da, Basile-Filho A. After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery [Internet]. Brazilian Journal of Cardiovascular Surgery. 2021 ; 36( 3): 406-411.[citado 2024 nov. 02 ] Available from: https://doi.org/10.21470/1678-9741-2021-0955

  • Artigo de periodico

    Ischemia/reperfusion injury revisited: an overview of the latest pharmacological strategies (2019)

    Soares, Ricardo Oliveira dos Santos; Losada, Daniele M.; Gomes, Maria Cecília Jordani ; Evora, Paulo Roberto Barbosa ; Castro e Silva, Orlando de

    Fonte: International Journal of Molecular Sciences. Unidade: FMRP

    Assuntos: ISQUEMIA, MITOCÔNDRIAS

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SOARES, Ricardo Oliveira dos Santos et al. Ischemia/reperfusion injury revisited: an overview of the latest pharmacological strategies. International Journal of Molecular Sciences, v. 20, n. 20, p. [45] , 2019Tradução . . Disponível em: https://doi.org/10.3390/ijms20205034. Acesso em: 02 nov. 2024.

    • APA

      Soares, R. O. dos S., Losada, D. M., Gomes, M. C. J., Evora, P. R. B., & Castro e Silva, O. de. (2019). Ischemia/reperfusion injury revisited: an overview of the latest pharmacological strategies. International Journal of Molecular Sciences, 20( 20), [45] . doi:10.3390/ijms20205034

    • NLM

      Soares RO dos S, Losada DM, Gomes MCJ, Evora PRB, Castro e Silva O de. Ischemia/reperfusion injury revisited: an overview of the latest pharmacological strategies [Internet]. International Journal of Molecular Sciences. 2019 ; 20( 20): [45] .[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/ijms20205034

    • Vancouver

      Soares RO dos S, Losada DM, Gomes MCJ, Evora PRB, Castro e Silva O de. Ischemia/reperfusion injury revisited: an overview of the latest pharmacological strategies [Internet]. International Journal of Molecular Sciences. 2019 ; 20( 20): [45] .[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/ijms20205034
  • 1

1 - 3 (3 registros)

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024